Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
710 Leser
Artikel bewerten:
(2)

INFORMA MARKETS - ENGINEERING: MEDevice Boston Grows in Attendance, Emphasizing Massachusetts's Regional Strength in MedTech

Finanznachrichten News

The annual event focused on innovation and emerging trends.

BOSTON, MA / ACCESSWIRE / October 28, 2024 / MEDeviceBoston, the most comprehensive New England event for the medical device manufacturing industry, highlighting technologies and key trends impacting healthcare, convened on September 26 with nearly 1,578 attendees, a 6% increase from its previous year. The annual expo hosted over 200 exhibiting companies.

Boston, home to over 20 hospitals and 20 community health centers, is highly regarded as a key national hub for the medical device manufacturing industry, with 1 in 5 workers in the area involved in the sector.

"Boston continues to be at the forefront of medical innovation as the third largest MedTech hub in the country," says Melissa Magestro, Vice President at Informa Markets Engineering. "The community comes together at MEDevice Boston to share new inventions, educate the industry on the latest topics, collaborate on emerging ideas and partner to move the industry forward. Gathering the most recognizable MedTech professionals at the north east's center for critical research and ingenuity, this platform creates those moments that spark our future.

Dr. Kevin J. Tracey, president and CEO of the Feinstein Institutes for Medical Research at Northwell Health, presented the keynote discussion reviewing recent methods to treat inflammation, using Vargas nerve stimulation and targeted bioelectronic medicine. Uncovering novel approaches and creative solutions to target long-term challenges with simplicity, highlights the value of cross-functional integration when problem solving in the medical device industry.

"Bioelectronic devices target nerve pathways to control molecular mechanisms that can be understood or masked or verified in detail, so it is not 'plug it in and see what happens to the patient.' The medicine really is the convergence of Molecular Medicine, neuroscience and biomedical engineering, and can [provide] benefit," shared Dr. Tracey on their application to address the age-old obstacle of inflammation.

The other keynote, "The Next Generation of Orthopedic Precision Medicine - Point-of-Care 3D Printed Exoskeletons," by Diana Hall, CEO, ActivArmor, explored how technology can create medical devices unique to each patient.

New this year, MEDevice Boston introduced several additional opportunities for networking and discovery including Quick Connect 1-1 Meetings for smart customized matchmaking and the ShopTalk Lounge, a dedicated space to connect with industry peers, engage in guided, meaningful conversations, and celebrate the advancements in medical device manufacturing. For the first time ever, MEDevice Boston also hosted "Reverse Pitches", where industry leading investors and strategic influencers pitched respective plans for portfolio growth, focus areas of investment and criteria sought for establishing partnerships, offering direct resources and contacts for start-ups and early-stage companies seeking partners and funding.

The Innovation Showcase returned highlighting a close look at pioneering products and materials entering the market this year, followed by an attendee vote on the best-in-show selections. Canvys, creator of custom monitors and panels for Original Equipment Manufacturers (OEMs), earned Innovation Excellence. KNF Neuberger, designer, producer and distributor of pumps and systems for gases, liquids, and vapors in the MedTech sector, won Product of the Year.

In true Boston fashion, MEDevice hosted its second annual Oktoberfest Welcome Reception, in partnership with 28Freight and Ascential Technologies. Guests were entertained with a rousing sampling of seasonal selections and an intimate chance to sip and mingle with festivity. Brave contestants participated in a traditional beer stein holding contest to prove their strength as they fought to hold their own among peers in the competitive MedTech industry.

MEDevice Silicon Valley, returns Nov. 20-21, 2024. In the heart of California's sleek technological epicenter, the medical device industry will converge to hear the latest and greatest from the drivers in the west coast.

To continue to stay up to date on the MEDevice community and expos, visit medevicesiliconvalley.com. Information is now available for scheduled sessions, speakers and workshop paths.

About Informa Markets Engineering:

Informa Markets Engineering, a subsidiary of Informa plc (LON:INF), portfolio is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa, the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit informamarkets.com.

Media Contact

Informa Markets Engineering
EngineeringPR@informa.com

SOURCE: INFORMA MARKETS - ENGINEERING



View the original press release on accesswire.com

© 2024 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.